Benefits
Antioxidant protection
Alpha-tocopherol is the main fat-soluble antioxidant in cell membranes, and EU regulators accept that vitamin E contributes to the protection of cells from oxidative stress. In a dose-ranging trial in adults with high cholesterol, a blood marker of lipid damage fell significantly only at 1,600 IU a day or more, above the upper limit.
Immune function in older adults
In healthy adults over 65, 200 mg a day for about 8 months improved skin test immune responses and hepatitis B vaccine antibodies. Trials counting infections gave mixed results: in nursing home residents fewer people had a cold but total infections did not fall, and in older adults living at home infections were no less frequent and were more severe.
LDL oxidation and heart outcomes
Vitamin E slows the oxidation of LDL cholesterol in laboratory studies, a step in plaque formation. In the HOPE trial, 400 IU a day did not reduce heart attacks, strokes or cardiovascular deaths in people with vascular disease or diabetes and raised the risk of heart failure. A lab effect on LDL should not be read as a heart benefit.
Skin response to UV light
In a 50-day randomized trial, 2 g a day of vitamin E alone produced no significant change in how easily skin burned in UV light. Only the combination with 3 g a day of vitamin C raised the sunburn threshold. The vitamin E dose was twice the adult upper limit, so this is not a reason to take vitamin E for skin.
Mechanism of action
Lipid peroxidation termination
Alpha-tocopherol donates a hydrogen atom to lipid peroxyl radicals (LOO•), converting them to lipid hydroperoxides and generating a tocopheroxyl radical, which is then regenerated by vitamin C. This interrupts the chain reaction of lipid peroxidation.
Gene expression regulation
In laboratory studies tocopherols change the activity of genes involved in inflammation (the NF-kB pathway), cell adhesion and immune cell development, apart from their antioxidant action.
Platelet aggregation inhibition
Vitamin E reduces platelet clumping in laboratory studies. This is the reason high doses can add to bleeding risk, and the US upper limit is based on this bleeding effect. It has not translated into fewer heart attacks or strokes in large trials.
Clinical trials
Randomized double-blind placebo-controlled trial of 400 IU a day of natural vitamin E in 9,541 people aged 55 or older with vascular disease or diabetes; the extension followed participants for a median 7 years. (Lonn et al. 2005, JAMA)
9,541 adults with vascular disease or diabetes.
No significant difference in cancer (RR 0.94), cancer deaths (RR 0.88) or major cardiovascular events (RR 1.04). Heart failure (RR 1.13) and hospitalization for heart failure (RR 1.21) were more common on vitamin E.
Randomized double-blind placebo-controlled trial of 60, 200 or 800 mg a day of vitamin E or placebo for 235 days. (Meydani et al. 1997, JAMA)
88 healthy free-living adults aged 65 or older.
The 200 mg group had a 65% increase in skin test (DTH) response and a 6-fold rise in hepatitis B vaccine antibodies, versus 17% and 3-fold on placebo, plus a rise in tetanus antibodies. There was no effect on diphtheria antibodies, immunoglobulin levels or T and B cell counts.
Randomized double-blind placebo-controlled trial of 200 IU a day of vitamin E for 1 year at 33 Boston-area nursing homes; all participants also got a half-RDA multivitamin. (Meydani et al. 2004, JAMA)
617 nursing home residents aged 65 or older; 451 completed.
No significant effect on the number of infections or infection days, overall, upper or lower. Fewer people on vitamin E had at least one respiratory infection (60% vs 68%, P=0.048) or at least one cold (40% vs 48%, P=0.05). Antibiotic use did not differ.
Randomized double-blind placebo-controlled 2 x 2 factorial trial of 200 mg a day of vitamin E, a multivitamin, both or placebo, median 441 days. (Graat et al. 2002, JAMA)
652 well-nourished adults aged 60 or older in the Netherlands.
Vitamin E did not lower the rate of acute respiratory infections (rate ratio 1.12, P=0.21). Infections in the vitamin E groups lasted longer (median 19 vs 14 days), had more symptoms and more often caused fever and restricted activity.
Randomized dose-ranging study of 0, 100, 200, 400, 800, 1,600 or 3,200 IU a day of natural vitamin E for 16 weeks, after a 20-week time-course study. (Roberts et al. 2007, Free Radic Biol Med)
Adults with polygenic high cholesterol and raised oxidative stress.
Plasma F2-isoprostanes, a marker of lipid peroxidation, fell in a dose-related way, reaching significance only at 1,600 IU (35% drop) and 3,200 IU (49% drop). The full effect took 16 weeks to appear.
Prospective randomized placebo-controlled trial of 2 g a day of vitamin E, 3 g a day of vitamin C, both, or placebo for 50 days, testing skin redness after simulated sunlight. (Fuchs and Kern 1998, Free Radic Biol Med)
Healthy volunteers.
Vitamin E alone raised vitamin E levels in skin cells but did not significantly change the sunburn response. Only the combination raised the minimal erythema dose, from 103 to 183 mJ/cm2.